Skip to content

Affect-based Impulsivity in Borderline Personality Disorder

Affect-based Impulsivity in Borderline Personality Disorder: Developing a Neurocomputational Phenotype

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06880640
Enrollment
106
Registered
2025-03-18
Start date
2025-09-21
Completion date
2026-08-01
Last updated
2026-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borderline Personality Disorder (BPD), Healthy Controls Group - Age and Sex-matched

Brief summary

The purpose of this research study is to investigate how personality traits and neuroendocrine systems relate to decision-making patterns in individuals 18-45 years old. The main question it aims to answer is how neuroendocrine activity impacts decision-making. Participants will complete online behavioral tasks, a stress induction procedure, self-report surveys, and a cognitive assessment. During the session, psychophysiological measures will be collected, including electrocardiogram (ECG) and cardiac impedance (ICG) to monitor heart rate and blood flow, as well as electrodermal activity (EDA), blood drop samples, and saliva collection to assess nervous system activity.

Interventions

Participants will complete the Trier Social Stress Test to induce stress, which includes a public speaking simulation and mental arithmetic.

Sponsors

University of North Carolina, Chapel Hill
Lead SponsorOTHER
North Carolina Translational and Clinical Sciences Institute
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

Borderline Personality Disorder (BPD) group: * Score of 38 or higher on Personality Assessment Inventory-Borderline Scale (PAI-BOR) * Participants in the BPD group will be primarily recruited from the two DEPENd lab studies that maintain large samples of BPD participants. To ensure maximal similarity between BPD participants recruited from other DEPENd lab studies and BPD participants recruited through other recruitment sources, the investigators will use the same criteria for the BPD group in the current study as the criteria used in the other DEPENd lab studies. BPD participants in the two DEPENd lab studies from which the investigators will be recruiting must meet the following criteria: 1. 3+ BPD symptoms, one of which must be affective instability, per clinical interview 2. Participants must score at least 80 on the Reynolds Intellectual Screening Test (RIST). Health Control (HC) Group: * Score of 12 or lower on PAI-BOR * Score below 50th percentile on World Health Organization Disability Assessment Schedule (WHODAS) * Absence of any current or lifetime psychiatric disorder, including personality disorders as determined by diagnostic interviews (SIDP and SCID), if the participant had participated in the lab's other studies (IRB Nos. 20-1735 and 21-0602). Combined Inclusion Criteria: * Ages 18-45 * Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study * Willingness to participate in all components of the study * Participants must be able to speak, understand and read English. * Participants must have at least 20/40 visual acuity (correct or uncorrected).

Exclusion criteria

* Use of as needed antihypertensive agents within 12 hours prior to lab visit * Inability to refrain from using as needed psychotropic medications for 12 hours prior to lab visit * History of psychotic disorder, Bipolar I disorder, autism spectrum disorder, reactive attachment disorder, pervasive developmental disorder, motor disorder, head injury, mental retardation, neurological disorder, or current substance dependence * Family history of Bipolar I disorder in a first degree relative. * Participants are also excluded for any of the following: cardiac pacemaker, aneurysm clip, cochlear implants, pregnancy, shrapnel, history of metal fragments in eyes, neurostimulators, weight of 250 lbs. or more, or claustrophobia.

Design outcomes

Primary

MeasureTime frameDescription
Goal-directed decision-making in the Social Decision Tree Task (SDTT)Collected for 40 minutes ~2 hours into one-time study visitMeasured by choice behavior in SDTT, which is based on the decision tree framework. After each action, participants receive feedback about the effect of that action and the extent to which it added to or took away from their points. If participants make a given choice, the subsequent actions that they can choose are different than if they were to initially make a different choice. An action in SDTT is goal-directed if the possible net gain an individual can earn before the end of the current epoch (a "day" in the SDTT) is equal to or higher than the amount they could gain by choosing the alternative action. The investigators will subset trials so that 1 is coded as choosing the immediately valuable action at the expense of the optimal and 0 is coded as choosing the optimal at the expense of the immediately valuable action. This outcome variable is binary.

Secondary

MeasureTime frameDescription
Bias toward social actions in the Social Decision Tree Task (SDTT)Collected for 40 minutes ~2 hours into one-time study visitMeasured by choice behavior in SDTT, which is based on the decision tree framework. An action in SDTT is defined as social if it is paired with a visual cue with a face on it and non-social if not. This outcome variable is binary.

Countries

United States

Contacts

CONTACTKeely A Muscatell, PhD
kmuscatell@unc.edu+1 (919) 843-9113
PRINCIPAL_INVESTIGATORKeely Muscatell, PhD

University of North Carolina, Chapel Hill

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 27, 2026